Health

FDA declares the shortage of obesity drug Zepbound has ended. The results are complicated

by Curtis Jones
written by Curtis Jones 0 comments

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

You may also like

Disability advocates say DOJ memo threatens community-based care : NPR

Flu outbreak tests new Pentagon vaccine policy

Who will help these nuns in their last years? : NPR

A top pulmonologist reviews advancements in the 'War on Cancer' over the past...

FDA committee unanimously recommends first mRNA flu vaccine : NPR

What the research says about the toys vs. tech plot in ‘Toy Story...

Leave a Comment

Save my name, email, and website in this browser for the next time I comment.

AdSense Space

Andy Murray: Two-time Wimbledon champion on coaching Jack Draper, Serena Williams’ comeback and keeping busy in retirement

Recent Articles

Kyle Schwarber hits three home runs, Bryce Harper cycles in Phillies rout
It’s Scottie Scheffler’s first dance with immortality. They don’t happen often
Wildfire in Central Utah Prompts Evacuation Order for Hundreds of People

Featured

Andy Murray: Two-time Wimbledon champion on coaching Jack Draper, Serena Williams’ comeback and keeping busy in retirement
Kyle Schwarber hits three home runs, Bryce Harper cycles in Phillies rout
It’s Scottie Scheffler’s first dance with immortality. They don’t happen often

@2025 – All Right Reserved. Designed and Developed by  Kaniz Fatema